Cubist Systematic Strategies, LLC Marker Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $79,537 - $136,350	-47,344 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.88 - $3.56 $46,317 - $87,707	-24,637 Reduced 34.23%	47,344 $132,000
Q1 2021 May 17, 2021	BUY	$1.47 - $3.29 $105,812 - $236,817	71,981 New	71,981 $161,000
Q3 2019 Nov 14, 2019	SELL	$4.1 - $9.0 $93,996 - $206,334	-22,926 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $118,068 - $181,573	22,926 New	22,926 $182,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $134M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.